Litigation Details for Alza Corporation v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2014)
✉ Email this page to a colleague
Alza Corporation v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2014)
Docket | ⤷ Sign Up | Date Filed | 2014-05-15 |
Court | District Court, N.D. West Virginia | Date Terminated | 2015-10-16 |
Cause | 35:145 Patent Infringement | Assigned To | Irene Patricia Murphy Keeley |
Jury Demand | Referred To | Michael J. Aloi | |
Patents | 8,163,798 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Alza Corporation v. Mylan Pharmaceuticals Inc.
Details for Alza Corporation v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2015-07-06 | 127 | CONSTRUING PATENT CLAIMS This patent infringement case involves United States patent 8,163,798 (“the…this patent infringement action against Mylan pursuant to the Drug Price Competition and Patent Term …entire patent, including the specification.” Id. When construing patent claims… Id. at 1314. Because a patent will ordinarily use patent terms consistently, “the usage of…construe the patent claims as being limited to a single embodiment simply because the patent describes | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |